Try our Advanced Search for more refined results
Health - May, 2011
216 articles
- FDA Probes Yaz, Others Over Blood Clot Risks
- Orthovita Shareholders Sue Over $316M Stryker Deal
- WHO Says Cellphone Radiation May Cause Cancer
- Pfizer Ends Patent War Over Generic Neurontin
- High Court Won't Hear Novartis Appeal Of Zometa Suit
- Following Follow-On Biologics Legislation
- 10 Tips To Ensure Your Trust Account Is Secure
- The Hidden Risks Of Being A Registered Agent
- Abbott Sues Boehringer Unit Over Generic Zemplar
- Galderma, Supernus Sue Impax Over Rosacea Treatment
- Ky. Jury Favors Rawlings In OT Class Action
- Somaxon Slaps Par With 2nd Suit Over Generic Silenor
- ARB Ruling Offers Broad View Of SOX Protections
- Exporter Admits To $1.3M FDA Fraud
- HP, Quest Sued Over Medical Records Software Patent
- The HEAT Is On, Chicago: Practical Tips To Prepare
- SG Sides Against Novo In Dispute Over Generics
- Attys' Collaboration Fight To Stay In Federal Court
- Medicaid Can Seek Money From Insurers: Mont. Court
- Judge Refuses To Toss Botox Marketing Class Action
- Fresenius Must Pay $83M For Medicare Overcharges
- Fed. Circ. To Rehear McKesson Joint Infringement Case
- Q&A With Crowell & Moring's Jennifer Romano
- Amylin Wins Restraining Order On Lilly Drug Sales
- Jury Sides With Novartis In Widow's Bone Drug Suit
- GSK, Pfizer, Others Targeted In DNA Patent Suit
- Considering Cross-Border M&A In The Middle East
- IP Lawyers Weigh In On Inequitable Conduct Ruling
- Fed. Circ. Tightens Inequitable Conduct Standards
- Sanofi Paid Doctors To Help Delay Lovenox Generic: Sens.
- Medtronic's Infuse Tied To Male Infertility Risks
- 34 Women Sue AstraZeneca Over Nexium Bone Risks
- Plaintiffs, Claims Added To $100M Bayer Sex Bias Suit
- AstraZeneca Adds Intellipharmaceutics To Seroquel Row
- Watson Expands Generics Biz With $562M Specifar Buy
- FDA Issues Class 1 Recall Of Beckman Blood Analyzer
- MAS-Alere Merger Still On Despite Roche Suit: 7th Circ.
- Adviser Gets 2 Years For Trading On Ex-UBS Banker's Tips
- Apotex Infringed Alcon's Eye Drop Patent: Judge
- White House Cracks Down On Misuse Of Federal Cash
- FTC Urges 3rd Circ. To Reverse Pay-For-Delay Ruling
- Fed. Circ. Revives Competition Claims In Latisse Suit
- Defining The Essential Health Benefits Package
- Applied Medical Hits Covidien With Seal Patent Suit
- After Failed Cephalon Bid, Valeant Buys Sanitas For $443M
- Philips Recalls Infant, Neonatal CO2 Devices
- Mayer Brown Reps Nestle In Diagnostics Co. Buy
- PSS Sues Over Poached Clients, Trade Secrets
- JPML Consolidates Depuy Hip Implant Suits in Texas
- Judicial Panel Consolidates Fosamax Femur Fracture Suits
- JPML Won't Separate La. Avandia Suit From MDL
- Lessons From Southwest Health Alliance
- Pa. Jury Slaps J&J Unit With $10M Motrin Verdict
- J&J Buys Russian Cold Drug Brands For $260M
- High Court Preemption Ruling Would Hit Branded Cos. Hard
- XenoPort Investors' Horizant Suit Tossed For Now
- Wash. Hospital Workers Sue Over Racial Discrimination
- 4th Circ. Returns W.Va. Pharmacy Suit To State Court
- Contractor Sues AIG Unit Over Defense Of $44M Suit
- Cephalon Granted TRO In Amrix Patent MDL
- Mylan Settles Kentucky Drug-Pricing Suit For $6.5M
- Pfizer Resubmits Thousands Of Adverse Chantix Reports
- Allergan Hits Lupin With 2nd Eye Drop Patent Suit
- Novartis Seeks To Nix Expert Testimony In Bone Drug MDL
- 9th Circ. Nixes Pharmacies' Pfizer-Wyeth Merger Suit
- FBI Seeks Unabomber DNA Over 1982 Tylenol Deaths
- US Mandates Health Insurance Rate Hike Reviews
- 7th Circ. Upholds Black Lung Benefits Act Amendment
- Genentech Sues Apotex Over Generic Valcyte
- FDA Urged To Pull Eisai's High-Dose Aricept
- Exela Didn't Infringe Alphagan IP: Fed. Circ.
- Abbott Wins IP Validity Ruling In Niaspan Suit
- SEC Probes Embattled CHS' Medicare Billing
- GAO Denies Protest Of $3B MetLife Dental Contract
- CORRECTED: Mylan's Inequitable Conduct Claim Axed In Vytorin IP Suit
- Q&A With Morrison & Foerster's James Huston
- Takeda Goes Global With $13.7B Nycomed Deal
- WilmerHale Reps Thermo Fisher In $3.5B Phadia Buy
- FDA Pulls Avandia From US Pharmacies
- Firms, Experts Allowed To Stay In AndroGel MDL
- Nycomed, Glenmark Settle Feud Over Cutivate
- Revise Pain-Med Dosing Tips For Children: FDA Panels
- CVS, Rite Aid Strike Deal In OxyContin MDL
- The Limits Of Federal Rule Of Evidence 408
- Neurontin Judge Won't Certify 3rd-Party Bipolar Class
- FDA Warns Shire About Vyvanse Marketing
- NJ Class Suit Targets Bayer Probiotics Products
- Ex-Dallas Auditor Seeks Fast Win On Retaliation Claim
- Fla. Phlebotomist Sues Quest For OT Pay
- Ropes & Gray Reps InVentiv In PharmaNet Purchase
- 6th Circ. Upholds $101M Verdict Against HCP
- Schiff Nutrition Sued Over Dietary Supplement Claims
- Genzyme Sues Allergan Over Juvederm Gel IP
- Supreme Court Won't Hear Howmedica Polymer IP Appeal
- $100M Sex Bias Suit Barred By Contract: Cigna
- Ga. High Court Favors Vaccine Makers In Defect Case
- High Court Vacates Benefits Ruling For Cigna Class
- Amylin Sues Lilly Over Byetta Sales Plans
- Lupin Steps Up Fight With Mylan Over Generic Antara
- Policyholder Says John Alden Skimped On Health Coverage
- Fed. Circ. Upholds Rejection Of 2 Endo Opana Patents
- Lloyd's Doesn't Owe Bristol-Myers $11M For Theft: Suit
- NuAire Sues Wire Co. Over $1.8M Incubator Recall
- Life Partners, CEO, GC Could Face SEC Action
- CHS Faces Investor Suit Over Alleged Medicare Fraud
- Pfizer Expects To Pay $772M To End Hormone Drug Suits
- Cephalon's Amrix IP Invalid, Infringed: Judge
- I'm Glad High Court Nixed Cipro Cert Bid: FTC Commish
- 3rd Party Has Rights To Fraudster's Money: 7th Circ.
- Kinetic Unit Warned Over Breast Implant Marketing
- Executive Risk Must Cover Hospital Privacy Row: Judge
- US Seeks $1B From J&J Over Risperdal Marketing
- Advanced Generic Reloads In Antitrust Suit V. Drug Cos.
- Disgorgement: A Cure Worse Than The Disease?
- Possible Outcomes Of Stanford V. Roche
- GSK Beats ERISA Class Action Over Stock Price Drop
- 8th Circ. Won't Rehear KV Drug Recall Action
- Remedi Sues Zurich Over Medicare Suit Coverage
- Boston Scientific Wins $19.5M In Stent Patent Case
- Vets Have Due Process Right To Mental Care: 9th Circ.
- Cephalon Drops Nuvigil Patent Suit Against Teva
- Judge Snips DaVita Kickback Claims In FCA Suit
- FDA Asked To Probe 3M's MRSA Clinical Test Conduct
- Morgan Lewis Adds 2 McKenna Gov't Contract Pros
- Q&A With Sidley Austin's Thomas Hanrahan
- J&J Recalls HIV Drug Over Odor-Causing Chemical
- J&J Unit Sets Funds Aside For Risperdal Settlement
- Sanofi, Generics Failed To Report Ambien IP Deals: FTC
- FDA Orders 21 Hip Reserve Makers To Study Defects
- Whistleblower Told To Provide Docs In CHS Fraud Suit
- 4th Circ. Mulls Va. Standing In Health Care Law Fight
- Somaxon Sues Actavis Over Generic Silenor
- Aflac Can't Duck Class Action Over Child Premiums
- Pharmacies Attack $68B Pfizer-Wyeth Deal In 9th Circ.
- FTC Orders Texas Doctors Group To Stop Rate Talks
- 10th Circ. Keeps Farmers Class Action In Federal Court
- 11th Circ. Trims Scrushy Conviction Based On Skilling
- Insurer Balks At Coverage For ProMedica Merger Suit
- High-Ranking DOJ Fraud Cop Heads To Mintz Levin
- Wilson Sonsini Lures IP Litigator From Katten Muchin
- GSK Atty Acquitted On All Counts In Obstruction Case
- How Health Care Is Being Challenged
- Becton Syringe Doesn't Infringe MBO's Patent: Judge
- Tenet Healthcare Spurns CHS' $4B Final Merger Offer
- DOD Services Contracts Outpace Other Growth
- Forest Labs Subpoenaed Over Hypertension Meds
- Quest Agrees To Settle Calif. Medicaid Suit For $241M
- US Can't Prove Wellbutrin Statements False: GSK Atty
- Health Care Industry Feels The HEAT
- Reissue Ruling A Boost To Patentees In Validity Fights
- Howrey Lessons: The Downside Of Contingent Fees
- Lilly Claims Zydus Broke Deal In Strattera Row
- Cleary Gottlieb Reps Alkermes In $960M Elan Unit Buy
- Mass. Constitution Protects Legal Immigrants: Court
- NLRB Targets Nurses' Union Over Unilateral CBA Text
- Enzo Can't Dodge Siemens' DNA Patent Priority Suit
- Canada High Court To Hear Teva's Viagra Patent Appeal
- Ivera Sues Excelsior Over Medical Valve Patent
- Synthes Investor Blasts $21B J&J Deal In Suit
- Wright Medical In Hot Seat Over $8M Kickbacks Settlement
- FTC Clears $338M Baxter-Prism Pharmaceuticals Deal
- Merck Unit Sues Sandoz Over Generic Noxafil
- Morgan Lewis Criminal Defense Pro Jumps To Dickstein
- Crowell Picks Up Hatch-Waxman Experts From Frommer
- J&J Units Again Sue To Block Impax's Generic Concerta
- Inspire Shareholders Try To Block $430M Merck Takeover
- Antitrust Guidance For ACOs: Still Evolving
- Sedgwick Hit With $200M Malpractice Suit
- Bayer Targets Lilly In False Ad Suit Over Pet Drugs
- Yaz Consumers Fail To Win Class Cert. In MDL Case
- Conn. AG, CVS Settle Expired Products Suit
- Medtronic Loses Bid To Take Lenox Suit To Arbitration
- Doctors Were Chastised For Wellbutrin Claims: GSK Exec
- 2nd Circ. Upholds $4M Fine In Insider Trading Suit
- P&G Can't Escape Align False Ad Action
- DR Systems Sues 16 Cos. Over Medical Imaging Patent
- Flamel Takes Lupin To Court Over Generic Coreg
- 4 Found Guilty In $5.2M Medicare Fraud Scheme
- Off-Label Use OK When Not Promoted, GSK Exec Says
- States Open Fight Over Health Care Law In 11th Circ.
- Former Cigna Atty Returns To Take On GC Role
- Merck Units To Pay $44M In Rebif Whistleblower Suit
- UnitedHealth Beats FCA Suit Over Hospital Payments
- Jazz Hits Roxane With Patent Suit Over Xyrem
- Barnes & Thornburg Lands Ex-Faegre & Benson Co-Chair
- Prescriptions For FCPA Pain
- Investor Tries To Stop LabCorp's $85M Orchid Buyout
- MetLife Intervenes In Protest Of $2B Dental Contract
- Actelion Vows To Appeal Jury Verdict In Asahi Fight
- GSK Scripted Response For Wellbutrin Probe, Atty Says
- Investors Sue J&J Board Over $78M In Settlements
- Pay-For-Delay Deals Hit 7-Year High In 2010: FTC
- 2nd Circ. Rejects Nurses Review Of Class Cert. Denial
- Takeda Sues Mylan Over Prevacid Patents
- Hatch Pushes To Repeal State Medicaid Mandate
- Blank Rome Snags Ex-Cozen Life Sciences Chair
- Wyeth Improperly Delayed Generic Effexor: Suit
- Miami Health Care Cos. Admit To $200M Medicare Fraud
- Senate Probes Medtronic Decision To Nix GPO Contracts
- US Regulators Clamp Down On Illegal STD Drugs
- Abbott Slaps Teva With Suit Over Generic AndroGel
- Pfizer, Eon Settle Neurontin Patent Claims
- Taro Sues Suven To Block Generic Lice Treatment
- Case Study: Wolfe V. McNeil-PPC
- FDA Gets Mylan Suit Over Generic Lipitor Tossed
- Impax Gets Amgen Vet As New GC
- AstraZeneca Ends Seroquel Case Against Biovail
- Santarus Defends Zegerid Patents In Fed. Circ.
- CHS Offers $4B Last-Ditch Bid For Tenet Healthcare
- FTC Clears Pfizer's $2.4B Capsugel Sale To KKR
- Grifols, FTC Ink Deal To Allow $3.4B Talecris Tie-Up
- Jones Day Lures M&A Pro From Edwards Angell
- Medicines Co. Sues Dr. Reddy's Over Generic Angiomax
- Addressing Multiforum Deal Litigation
- Killing The Golden Goose
- Teva Tops Valeant With $6.8B Cephalon Buy